NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Co
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| NAMSCO Corporation (NASDAQ: NAMS) | Delayed: 21.58 +0.32 (1.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.26 | 52 Week High | $0.00 | |||
| Open | $21.25 | 52 Week Low | $0.00 | |||
| Day High | $21.79 | P/E | N/A | |||
| Day Low | $21.02 | EPS | $0.00 | |||
| Volume | 1,265,985 | |||||
